Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.

Novavax Inc. closed $10.57 below its 52-week high ($23.86), which the company reached on June 6th.

As levels of the coronavirus have increased in Missouri and across the country, the federal government has approved updated vaccines to protect against COVID-19. The virus itself has changed, and ...

Pfizer and BioNTech said drug regulator Health Canada approved their updated Covid-19 vaccine, which will be available in the coming weeks.

A factor that has changed over time is hospitalization due to severe COVID infections. On Aug. 1, the statewide seven-day ...

On Monday, Novavax Inc (NVAX) stock saw a decline, ending the day at $12.8 which represents a decrease of $-0.11 or -0.85% from the prior close of $12.91. The stock opened at $13.01 and touched a low ...

Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently ...

There's a new bulletin from Florida's surgeon general. Vaccine experts and historians interviewed for this article can’t ...

The NHS is offering autumn Covid boosters to the most vulnerable in October. Many pharmacies also now sell the Covid jab ...

According to Suyama, in 2023 the flu killed 44,000 people nationwide, while COVID killed 74,000 people. “So COVID was nearly ...

Novavax Inc. closed $11.06 below its 52-week high ($23.86), which the company achieved on June 6th.

The government has already disbursed more than 900 million free at-home COVID-19 tests, and will be reopening its free test ...